EFA is offering EUPATI Patient Expert Training Scholarships to Members – deadline extended!
Since 2022, EFA has been supporting its community of members with scholarships to participate in the European Patients’ Academy on Therapeutic Innovation’s...
Salbutamol is in shortage in Europe
On 6 June, the European Medicines Agency (EMA) added salbutamol, a life-saving medicine for chronic respiratory disease and especially for children...
EFA contributed to the EMA review of the first critical medicines list of the EU
EFA recently contributed to the European Medicines Agency (EMA) targeted stakeholder consultation which reviewed the first Union list of critical medicines...
EFA contributes to a consultation on strategic priorities of the EU health programme for 2025
Early June, EFA responded to the stakeholders’ consultation around the strategic priorities of the 2025 Annual Work Programme of the EU health programme...
Asthma inhalers and climate labelling for patients: EFA informs the new F-Gases labelling rules for MDIs
If you have asthma or COPD, you might be using an inhaler to help you manage your disease. Some inhalers use a gas, known as propellants, which delivers...
EFA calls on the WHO to include specific priorities for allergy and lung health in the future NCD plan
On 17 June, EFA submitted a response to a first stage consultation to update the WHO on its Global Action Plan (GAP) 2013–2020 for the prevention and...
European Lung Health Group presents the #KeepBreathing campaign to European Commission’s DG SANTE and DG CONNECT in Luxembourg
On 13 June, representatives from EFA and the European Respiratory Society (ERS), travelled to Luxembourg on behalf of the European Lung Health Group (ELHG)...
EFA attends EU HTA Stakeholder Network meeting in Brussels
The EU HTA Stakeholder Network meeting focused on the involvement of patients in the Health Technology Assessment (HTA) process. Together with the European...
EFA attends EAACI Congress 2024
EFA representatives Celine Demoulin and Susanna Palkonen attended the EAACI Congress 2024 in Valencia. This year’s theme revolved around revolutionising...
EFA brings the patient perspective into the EMA Guideline for immunotherapy and diagnosis of less common allergies
At the end of May, EFA submitted our allergy community response to a key consultation for the allergy patient community: a Guideline on the development...
Join patients on World Atopic Eczema Day 2024 – toolkit now available!
This year’s #AtopicEczemaUnfiltered campaign will bring to the forefront the real experiences of people living with Atopic Eczema and shed light on the...
EFA joins the IDEAL Cluster Annual General Meeting 2024 on indoor air quality and health
As a partner of the EU Horizon research project 'SynAir-G' and a member of the 'IDEAL research Cluster', EFA joined the IDEAL Annual General Meeting 2024...
World No Tobacco Day 2024: Youth voices in support of recent tobacco restrictions in Spain
On World No Tobacco Day 2024, EFA Allergy and Asthma Youth Parliament member from Spain, Idoia Morán dives into the issues around youth smoking. Together...
EFA joins the EU Healthy Air Coalition as a founding member
EFA is pleased to be part of the EU Healthy Air Coalition (EUHAC) as a founding member. Launched in mid-April, the coalition brings together organisations...
EFA response to the European Commission consultation on Joint Clinical Assessment for HTA
In April 2024, EFA responded to the Health Technology Assessment (HTA) stakeholder consultation on the first implementing act of the EU HTA Regulation,...
EFA contributes to key technical study on indoor pathogens that are responsible for infectious respiratory diseases
EFA brings in the perspective of allergy and asthma patients to a new study published by the European Commission JRC and HERA. This research brings a new...
EFA brings the voice of allergy and respiratory patients at EU event on climate resilience in healthcare
In the event of the first EU Climate Risk Assessment published in March, EFA was invited as panellist to present the civil society perspective on climate...
EFA presents its plans to ‘raise the bar in respiratory care’ at EUFOREA Symposium
EFA brings to the EUROFEA Symposium EFA’s work contributing to better respiratory care in Europe: the upcoming ‘COPD standards of care – raising...
EFA response to Codex consultation on the use of technology for food labelling
As observer to the Codex Alimentarius Commission, EFA participated in another round of consultations for a guideline on the use of technology in food labelling....
World Asthma Day 2024: EFA launches aboutasthma.org, an innovative tool for asthma patients and carers
Today is World Asthma Day 2024! Did you know that over 30 million people in Europe, including a significant number of children, are living with asthma?...